BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 36573915)

  • 21. Determination of Parkinson Disease Laterality After Deep Brain Stimulation Using 123I FP-CIT SPECT.
    Park HR; Ha S; Lee DS; Im HJ; Paek SH
    Clin Nucl Med; 2020 Apr; 45(4):e178-e184. PubMed ID: 32108695
    [TBL] [Abstract][Full Text] [Related]  

  • 22. SW2-year outcomes of subthalamic deep brain stimulation for idiopathic Parkinson's disease.
    Nunta-Aree S; Sitthinamsuwan B; Boonyapisit K; Pisarnpong A
    J Med Assoc Thai; 2010 May; 93(5):529-40. PubMed ID: 20524438
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of elderly and young patient populations treated with deep brain stimulation for Parkinson's disease: long-term outcomes with up to 7 years of follow-up.
    Hanna JA; Scullen T; Kahn L; Mathkour M; Gouveia EE; Garces J; Evans LM; Lea G; Houghton DJ; Biro E; Bui CJ; Sulaiman OA; Smith RD
    J Neurosurg; 2018 Sep; 131(3):807-812. PubMed ID: 30265192
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Brain TRODAT-SPECT Versus MRI Morphometry in Distinguishing Early Mild Parkinson's Disease from Other Extrapyramidal Syndromes.
    Hossein-Tehrani MR; Ghaedian T; Hooshmandi E; Kalhor L; Foroughi AA; Ostovan VR
    J Neuroimaging; 2020 Sep; 30(5):683-689. PubMed ID: 32557946
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of Subthalamic Deep Brain Stimulation on Levodopa-Induced Dyskinesia in Parkinson's Disease.
    Kim JH; Chang WS; Jung HH; Chang JW
    Yonsei Med J; 2015 Sep; 56(5):1316-21. PubMed ID: 26256974
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Different effectiveness of subthalamic deep brain stimulation in Parkinson's disease: A comparative cohort study at 1 year and 5 years.
    Jiang JL; Chen SY; Hsieh TC; Lee CW; Lin SH; Tsai ST
    J Formos Med Assoc; 2015 Sep; 114(9):835-41. PubMed ID: 24103710
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Beneficial effects of bilateral subthalamic stimulation on alexithymia in Parkinson's disease.
    Dafsari HS; Ray-Chaudhuri K; Mahlstedt P; Sachse L; Steffen JK; Petry-Schmelzer JN; Dembek TA; Reker P; Barbe MT; Visser-Vandewalle V; Fink GR; Timmermann L
    Eur J Neurol; 2019 Feb; 26(2):222-e17. PubMed ID: 30107062
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bilateral subthalamic deep brain stimulation is an effective and safe treatment option for the older patients with Parkinson's disease.
    Kim M; Cho KR; Park JH; Ahn JH; Cho JW; Park S; Lee JI; Youn J
    Clin Neurol Neurosurg; 2018 Oct; 173():182-186. PubMed ID: 30149306
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reproducibility of 99mTc-TRODAT-1 SPECT measurement of dopamine transporters in Parkinson's disease.
    Hwang WJ; Yao WJ; Wey SP; Ting G
    J Nucl Med; 2004 Feb; 45(2):207-13. PubMed ID: 14960637
    [TBL] [Abstract][Full Text] [Related]  

  • 30. EuroInf 2: Subthalamic stimulation, apomorphine, and levodopa infusion in Parkinson's disease.
    Dafsari HS; Martinez-Martin P; Rizos A; Trost M; Dos Santos Ghilardi MG; Reddy P; Sauerbier A; Petry-Schmelzer JN; Kramberger M; Borgemeester RWK; Barbe MT; Ashkan K; Silverdale M; Evans J; Odin P; Fonoff ET; Fink GR; Henriksen T; Ebersbach G; Pirtošek Z; Visser-Vandewalle V; Antonini A; Timmermann L; Ray Chaudhuri K;
    Mov Disord; 2019 Mar; 34(3):353-365. PubMed ID: 30719763
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dopamine transporter imaging using 99mTc-TRODAT-1 SPECT in Parkinson's disease.
    Bor-Seng-Shu E; Felicio AC; Braga-Neto P; Batista IR; Paiva WS; de Andrade DC; Teixeira MJ; de Andrade LA; Barsottini OG; Shih MC; Bressan RA; Ferraz HB
    Med Sci Monit; 2014 Aug; 20():1413-8. PubMed ID: 25109468
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Outcome of bilateral subthalamic nucleus stimulation in the treatment of Parkinson's disease: correlation with intra-operative multi-unit recordings but not with the type of anaesthesia.
    Lefaucheur JP; Gurruchaga JM; Pollin B; von Raison F; Mohsen N; Shin M; Ménard-Lefaucheur I; Oshino S; Kishima H; Fénelon G; Rémy P; Cesaro P; Gabriel I; Brugières P; Keravel Y; Nguyen JP
    Eur Neurol; 2008; 60(4):186-99. PubMed ID: 18667827
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of Awake vs. Asleep Surgery for Subthalamic Deep Brain Stimulation in Parkinson's Disease.
    Blasberg F; Wojtecki L; Elben S; Slotty PJ; Vesper J; Schnitzler A; Groiss SJ
    Neuromodulation; 2018 Aug; 21(6):541-547. PubMed ID: 29532560
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Brain connectivity changes when comparing effects of subthalamic deep brain stimulation with levodopa treatment in Parkinson's disease.
    Mueller K; Jech R; Růžička F; Holiga Š; Ballarini T; Bezdicek O; Möller HE; Vymazal J; Růžička E; Schroeter ML; Urgošík D
    Neuroimage Clin; 2018; 19():1025-1035. PubMed ID: 30035027
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bilateral deep brain stimulation of the pedunculopontine and subthalamic nuclei in severe Parkinson's disease.
    Stefani A; Lozano AM; Peppe A; Stanzione P; Galati S; Tropepi D; Pierantozzi M; Brusa L; Scarnati E; Mazzone P
    Brain; 2007 Jun; 130(Pt 6):1596-607. PubMed ID: 17251240
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Investigating the role of 99mTc-TRODAT-1 SPECT imaging in idiopathic Parkinson's disease.
    Geng Y; Shi GH; Jiang Y; Xu LX; Hu XY; Shao YQ
    J Zhejiang Univ Sci B; 2005 Jan; 6(1):22-7. PubMed ID: 15593387
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Beneficial nonmotor effects of subthalamic and pallidal neurostimulation in Parkinson's disease.
    Dafsari HS; Dos Santos Ghilardi MG; Visser-Vandewalle V; Rizos A; Ashkan K; Silverdale M; Evans J; Martinez RCR; Cury RG; Jost ST; Barbe MT; Fink GR; Antonini A; Ray-Chaudhuri K; Martinez-Martin P; Fonoff ET; Timmermann L;
    Brain Stimul; 2020; 13(6):1697-1705. PubMed ID: 33038595
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Relationship Between Iron Distribution in Deep Gray Matter Nuclei Measured by Quantitative Susceptibility Mapping and Motor Outcome After Deep Brain Stimulation in Patients With Parkinson's Disease.
    Zhao W; Yang C; Tong R; Chen L; Chen M; Gillen KM; Li G; Ma C; Wang Y; Wu X; Li J
    J Magn Reson Imaging; 2023 Aug; 58(2):581-590. PubMed ID: 36594513
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Eight-year follow-up outcome of subthalamic deep brain stimulation for Parkinson's disease: Maintenance of therapeutic efficacy with a relatively low levodopa dosage and stimulation intensity.
    Jiang L; Chen W; Guo Q; Yang C; Gu J; Xian W; Liu Y; Zheng Y; Ye J; Xu S; Hu Y; Wu L; Chen J; Qian H; Fu X; Liu J; Chen L
    CNS Neurosci Ther; 2021 Nov; 27(11):1366-1373. PubMed ID: 34350691
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Simultaneous bilateral stereotactic procedure for deep brain stimulation implants: a significant step for reducing operation time.
    Fonoff ET; Azevedo A; Angelos JS; Martinez RC; Navarro J; Reis PR; Sepulveda ME; Cury RG; Ghilardi MG; Teixeira MJ; Lopez WO
    J Neurosurg; 2016 Jul; 125(1):85-9. PubMed ID: 26684776
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.